Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic G Barr

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Oncogene|August 3, 2004
Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoproteinShujuan J Xia, Frederic G Barr
The Journal of Molecular Diagnostics : JMD|July 27, 2007
Molecular diagnosis of ewing family tumors: too many fusions... ?Frederic G Barr, Richard B Womer
Current Opinion in Oncology|July 20, 2002
Chromosomal translocations and sarcomasJeannette L Bennicelli, Frederic G Barr
Molecules (Basel, Switzerland)|October 31, 2018
Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in RhabdomyosarcomaThanh Hung Nguyen, Frederic G Barr
Advances in Anatomic Pathology|October 12, 2013
Classification of rhabdomyosarcoma and its molecular basisDavid M Parham, Frederic G Barr
Cancers|March 13, 2024
The PAX Genes: Roles in Development, Cancer, and Other DiseasesTaryn Shaw, Frederic G Barr, Aykut Üren
Cancer Biology & Therapy|August 13, 2002
Molecular pathogenesis of rhabdomyosarcomaShujuan J Xia, Joseph G Pressey, Frederic G Barr
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 14, 2007
Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoproteinShujuan J Xia, Prerna Rajput, Donna M Strzelecki, et al.
Gene|May 7, 2018
The expression and function of PAX3 in development and diseaseSalah Boudjadi, Bishwanath Chatterjee, Wenyue Sun, et al.
The American Journal of Pathology|September 6, 2002
Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinomaMelinda E Sanders, Rosemarie Mick, John E Tomaszewski, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Oncogene|August 3, 2004
Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoproteinShujuan J Xia, Frederic G Barr
The Journal of Molecular Diagnostics : JMD|July 27, 2007
Molecular diagnosis of ewing family tumors: too many fusions... ?Frederic G Barr, Richard B Womer
Current Opinion in Oncology|July 20, 2002
Chromosomal translocations and sarcomasJeannette L Bennicelli, Frederic G Barr
Molecules (Basel, Switzerland)|October 31, 2018
Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in RhabdomyosarcomaThanh Hung Nguyen, Frederic G Barr
Advances in Anatomic Pathology|October 12, 2013
Classification of rhabdomyosarcoma and its molecular basisDavid M Parham, Frederic G Barr
Cancers|March 13, 2024
The PAX Genes: Roles in Development, Cancer, and Other DiseasesTaryn Shaw, Frederic G Barr, Aykut Üren
Cancer Biology & Therapy|August 13, 2002
Molecular pathogenesis of rhabdomyosarcomaShujuan J Xia, Joseph G Pressey, Frederic G Barr
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 14, 2007
Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoproteinShujuan J Xia, Prerna Rajput, Donna M Strzelecki, et al.
Gene|May 7, 2018
The expression and function of PAX3 in development and diseaseSalah Boudjadi, Bishwanath Chatterjee, Wenyue Sun, et al.
The American Journal of Pathology|September 6, 2002
Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinomaMelinda E Sanders, Rosemarie Mick, John E Tomaszewski, et al.
Pageof 11